These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9529694)

  • 1. Failure of fluoxetine to modify the skin-picking behaviour of Prader-Willi syndrome.
    Schepis C; Failla P; Siragusa M; Palazzo R; Romano C
    Australas J Dermatol; 1998 Feb; 39(1):57-8. PubMed ID: 9529694
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychosis associated with fluoxetine in Prader-Willi syndrome.
    Hergüner S; Motavalli Mukaddes N
    J Am Acad Child Adolesc Psychiatry; 2007 Aug; 46(8):944-945. PubMed ID: 17667473
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacologic treatment of severe skin-picking behaviors in Prader-Willi syndrome. Two case reports.
    Warnock JK; Kestenbaum T
    Arch Dermatol; 1992 Dec; 128(12):1623-5. PubMed ID: 1456757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggravation of food-related behavior in an adolescent with Prader-Willi syndrome treated with fluvoxamine and fluoxetine.
    Kohn Y; Weizman A; Apter A
    Int J Eat Disord; 2001 Jul; 30(1):113-7. PubMed ID: 11439417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone and fluoxetine in Prader-Willi syndrome.
    Benjamin E; Buot-Smith T
    J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):870-3. PubMed ID: 8340312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of naltrexone for treating pathologic skin picking behavior in an adolescent with Prader-Willi syndrome.
    Banga A; Connor DF
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):396-8. PubMed ID: 23083028
    [No Abstract]   [Full Text] [Related]  

  • 7. Self-injurious behavior and serotonin in Prader-Willi syndrome.
    Hellings JA; Warnock JK
    Psychopharmacol Bull; 1994; 30(2):245-50. PubMed ID: 7831463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric disorders in Prader-Willi syndrome: epidemiology and management.
    Dykens E; Shah B
    CNS Drugs; 2003; 17(3):167-78. PubMed ID: 12617696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychogenic excoriation responding to fluoxetine: a case report.
    Sharma H
    J Indian Med Assoc; 2008 Apr; 106(4):245, 262. PubMed ID: 18828345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onset of menses in two adult patients with Prader-Willi syndrome treated with fluoxetine.
    Warnock JK; Clayton AH; Shaw HA; O'Donnell T
    Psychopharmacol Bull; 1995; 31(2):239-42. PubMed ID: 7491374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate effectiveness in Prader-Willi syndrome.
    Smathers SA; Wilson JG; Nigro MA
    Pediatr Neurol; 2003 Feb; 28(2):130-3. PubMed ID: 12699864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of fluoxetine in an adolescent with Prader-Willi syndrome.
    Dech B; Budow L
    J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):298-302. PubMed ID: 2016235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutical approach of obesity in Prader-Willi Syndrome].
    Carvalho DF; Cercato C; Almeida MQ; Mancini MC; Halpern A
    Arq Bras Endocrinol Metabol; 2007 Aug; 51(6):913-9. PubMed ID: 17934657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperphagia and self-mutilation in Prader-Willi syndrome: psychopharmacological issues.
    Yaryura-Tobias JA; Grunes MS; Bayles ME; Neziroglu F
    Eat Weight Disord; 1998 Dec; 3(4):163-7. PubMed ID: 10728166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anomalous basal ganglia connectivity and obsessive-compulsive behaviour in patients with Prader Willi syndrome.
    Pujol J; Blanco-Hinojo L; Esteba-Castillo S; Caixàs A; Harrison BJ; Bueno M; Deus J; Rigla M; Macià D; Llorente-Onaindia J; Novell-Alsina R
    J Psychiatry Neurosci; 2016 Jun; 41(4):261-71. PubMed ID: 26645739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, controlled clinical trial of the efficacy of fluoxetine for treatment of compulsive disorders in dogs.
    Irimajiri M; Luescher AU; Douglass G; Robertson-Plouch C; Zimmermann A; Hozak R
    J Am Vet Med Assoc; 2009 Sep; 235(6):705-9. PubMed ID: 19751167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine-Induced Skin Picking and Compulsive Behaviors in a Preschool Girl.
    Çoşkun F; Bilgiç A
    Clin Neuropharmacol; 2018; 41(5):192-193. PubMed ID: 30024442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal behavior case of the month. Motivation for the tail-chasing behavior was considered to most likely be multifactorial.
    Bain MJ; Fan CM
    J Am Vet Med Assoc; 2012 Mar; 240(6):673-5. PubMed ID: 22380802
    [No Abstract]   [Full Text] [Related]  

  • 19. Emergence of compulsive behavior and tantrums in children with Prader-Willi syndrome.
    Dimitropoulos A; Feurer ID; Butler MG; Thompson T
    Am J Ment Retard; 2001 Jan; 106(1):39-51. PubMed ID: 11246711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine augmentation of fluoxetine in the treatment of pathological skin picking.
    Christensen RC
    Can J Psychiatry; 2004 Nov; 49(11):788-9. PubMed ID: 15633864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.